Research Appraisalother

Teaching artificial intelligence through drug-drug interaction clustering analysis: Integrating project-based learning and large language models.

PLoS computational biologyLv, Ji, Liu, Guixia, Zhou, Changjun1 May 2026DOI

Clinical Snapshot

45CEBM
Evidence: Weakother

PICO Framework

P — PopulationEarly-stage undergraduate students from non-computing backgrounds
I — InterventionAI course integrating project-based learning with large language models (LLMs) using drug-drug interaction clustering analysis
C — ComparatorTraditional AI courses targeting computer science majors
O — OutcomesDevelopment of problem-solving skills, student engagement, and AI literacy

Bottom Line

This educational intervention proposes an innovative approach to teaching AI concepts to non-computing undergraduates through drug-drug interaction analysis and large language model integration. While the framework addresses an important educational gap and offers a practical methodology, the study lacks rigorous evaluation with validated outcome measures, control groups, and quantitative results. The preliminary nature of the findings limits confidence in effectiveness. For Australian medical educators, this approach could inform curriculum development for AI literacy, particularly relevant given increasing AI applications in healthcare and regulatory environments. However, formal evaluation studies with robust methodology are needed before widespread implementation. The integration of real-world pharmaceutical data analysis provides authentic learning experiences that could enhance student engagement and practical skills development.

Evidence: Weak

Key Findings

  • P Value: Not reported

  • Effect Size: Not reported

  • Primary Outcome: Preliminary feedback indicating support for problem-solving skills development and increased student engagement

  • Nnt Or Sensitivity: Not applicable - educational intervention without quantitative measures

  • Confidence Interval: Not reported

Clinical Application

Moderate - requires access to LLM tools and computational resources, plus faculty training in AI applications Relevant to Australian universities implementing AI literacy requirements. Could align with TGA's increasing focus on AI in drug regulation and RACGP's digital health competencies Undergraduate students in health sciences, pharmacy, and related fields seeking AI literacy

Abstract

In recent years, artificial intelligence (AI) has increasingly influenced daily life and scientific research. Traditionally, AI-related courses have targeted computer science majors, while systematic instructional opportunities for early-stage undergraduates from non-computing backgrounds remain limited. To bridge this gap, we developed an AI course that integrates project-based learning with large language models (LLMs). Specifically, we designed four progressive assignments based on our research project (i.e., drug-drug interaction network clustering analysis). The course does not require prior knowledge of pharmacology or programming. Instead, LLMs are used as assistive tools to support programming, data analysis, and result interpretation. Students engage in a complete workflow, including data curation, algorithm implementation, and critical evaluation of results. Preliminary feedback shows that this approach supports the development of problem-solving skills and increases student engagement. This study provides a framework for integrating LLMs into project-based learning. We believe that this teaching proposal will be valuable and inspiring for educators seeking to design or enrich similar courses.

References

  1. 1.Lv, J., Liu, G., & Zhou, C. (2026). Teaching artificial intelligence through drug-drug interaction clustering analysis: Integrating project-based learning and large language models. PLoS Computational Biology, 22(5), e1014236. https://doi.org/10.1371/journal.pcbi.1014236
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service